CIM
IDXX icon

Calvert Investment Management’s Idexx Laboratories IDXX Stock Holding History

Calvert Investment Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-36,534
Closed -$4.28M – 282
2016
Q4 		$4.28M Sell
36,534
-482
-1% -$55K 0.16% 187
2016
Q3 		$4.17M Buy
37,016
+31,619
+586% +$3.33M 0.15% 190
2016
Q2 		$501K Buy
5,397
+199
+4% +$17.1K 0.02% 502
2016
Q1 		$407K Buy
5,198
+873
+20% +$62.9K 0.02% 534
2015
Q4 		$315K Buy
4,325
+844
+24% +$60.2K 0.01% 554
2015
Q3 		$258K Buy
3,481
+136
+4% +$9.74K 0.01% 515
2015
Q2 		$215K Sell
3,345
-749
-18% -$51.9K 0.01% 587
2015
Q1 		$316K Buy
4,094
+360
+10% +$28K 0.02% 486
2014
Q4 		$277K Buy
3,734
+42
+1% +$2.94K 0.02% 488
2014
Q3 		$218K Buy
+3,692
New +$233K 0.02% 528

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Calvert Investment Management's IDXX Position: Q1 2017 in Review

Calvert Investment Management sold out of Idexx Laboratories (IDXX) in Q1 2017, closing a stake of 36,534 shares — an estimated $4.28M sold.

Calvert Investment Management first reported a position in IDXX in Q3 2014 and held it in 10 quarters. The position peaked at $4.28M in Q4 2016. 542 funds tracked by Wall St. Rank hold IDXX as of Q1 2017.

  • Calvert Investment Management reported no remaining Idexx Laboratories position as of Q1 2017 after selling out during the quarter.
  • Calvert Investment Management sold 36,534 Idexx Laboratories shares in Q1 2017, an estimated $4.28M.
  • Calvert Investment Management first reported a position in Idexx Laboratories in Q3 2014 and held it in 10 quarters.
  • Calvert Investment Management's Idexx Laboratories position peaked at $4.28M in Q4 2016.
  • 542 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2017.

Based on Calvert Investment Management's 13F filing for Q1 2017.